Active Shortage

ANTICOAGULANT SODIUM CITRATE SOLUTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ANTICOAGULANT SODIUM CITRATE SOLUTION, USP in Canada?

Yes. ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4G has an active shortage reported to Health Canada (last updated September 24, 2026).

Why is ANTICOAGULANT SODIUM CITRATE SOLUTION, USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ANTICOAGULANT SODIUM CITRATE SOLUTION, USP be available again?

The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Expected resolution~18 days remaining (estimate)

Affected strength4G

Last updated2026-09-24

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

ANTICOAGULANT SODIUM CITRATE SOL 4% USP

CUTTER MED & BIOL, DIVISION OF MILES CANADA LTD.

4% · DIN 00572357

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02529637

Strength

Dosage Form

SOLUTION

Route

EXTRACORPOREAL 0-UNASSIGNED

Active Ingredient

SODIUM CITRATE

See all SODIUM CITRATE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-24

Active Shortage

Disruption of the manufacture of the drug.

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482